[Federal Register Volume 76, Number 159 (Wednesday, August 17, 2011)]
[Notices]
[Pages 51036-51037]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-20919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-11-0802]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Daniel Holcomb, CDC Reports Clearance Officer,
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Active Bacterial Core Surveillance (ABCs) Projects--OMB 0920-0802,
Expiration January 31, 2012 (Revision)--National Center for
Immunization and Respiratory Disease (NCIRD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a revision to the approved data collection
instruments for Active Bacterial Core surveillance (ABCs), to add
supplemental questions for invasive methicillin-resistant
Staphylococcus aureus (MRSA). CDC requests OMB approval to collect
supplemental information to assess risk factors for invasive MRSA among
patients recently discharged from acute care hospitals. Seventeen acute
care facilities in 7 ABCs/EIP sites (CA, CT, CO, GA, NY, MN, TN) will
participate in the collection of supplemental information for ABCs
MRSA.
Preventing healthcare-associated invasive MRSA infections is one of
CDC's priorities. Essential steps in reducing the occurrence of
healthcare-associated invasive MRSA infections are to quantify the
burden and to identify modifiable risk factors associated with invasive
MRSA disease. The current ABCs MRSA surveillance has been essential to
quantify the burden of invasive MRSA in the United States. Through this
surveillance CDC was able to estimate that 94,360 invasive MRSA
infections associated with 18,650 deaths occurred in the United States
in 2005. The majority of these infections (58%) had onset in the
community or within 3 days of hospital admission and occurred among
individuals with recent healthcare exposures (healthcare-associated
community-onset [HACO]). More recent data from the CDC's EIP/ABCs
system have shown that two thirds of invasive HACO MRSA infections
occur among persons who are discharged from an acute care hospital in
the prior 3 months. Risk factors for invasive MRSA infections post-
discharge have not been well evaluated, and effective prevention
measures in this population remain uncertain.
The goal of the supplemental questions to be added to ABCs MRSA
surveillance is to assess risk factors for invasive healthcare-
associated MRSA infections, which will inform the development of
targeted prevention measures. This activity supports the HHS Action
Plan for elimination of healthcare-associated infections. This change
will result in minimal impact on the current public burden.
[[Page 51037]]
An estimated total of 450 new patients (150 patients with HACO MRSA
infection and 300 patients without HACO MRSA infection) will be
contacted for the MRSA interview annually. This estimate is based on
the numbers of MRSA cases reported by the EIP sites annually (http://www.cdc.gov/abcs/reports-findings/survreports/mrsa08.html) who are 18
years of age or older, had onset of the MRSA infection in the community
or within 3 days of hospital admission, and history of hospitalization
in the prior 3 months. There are no costs to respondents other than
their time. The total response burden for the study is estimated as
follows:
The OMB-approved ABCs MRSA form (0920-0802) will be used
to identify patients to be contacted for a telephone interview. These
450 patients will be screened for eligibility and those considered to
be eligible will complete the telephone interview. We anticipate that
350 of the 450 patients screened will complete the telephone interview
across all 7 EIP sites per year. We anticipate the screening questions
to take about 5 minutes and the telephone interview 20 minutes per
respondent.
Table--Estimated Burden
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per respondent (in hours)
respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Hospital Patients............. Screening Form.. 450 1 5/60 38
Telephone 350 1 20/60 117
interview.
----------------------------------------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 155
----------------------------------------------------------------------------------------------------------------
Dated: August 10, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-20919 Filed 8-16-11; 8:45 am]
BILLING CODE 4163-18-P